↓ Skip to main content

Depot perphenazine decanoate and enanthate for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2005
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Depot perphenazine decanoate and enanthate for schizophrenia
Published in
Cochrane database of systematic reviews, July 2005
DOI 10.1002/14651858.cd001717.pub2
Pubmed ID
Authors

Anthony David, Seema N Quraishi, John Rathbone

Abstract

Antipsychotic drugs are usually given orally but compliance with medication given by this route may be difficult to quantify. The development of depot injections in the 1960s gave rise to extensive use of depots as a means of long-term maintenance treatment. Perphenazine decanoate and enanthate are depot antipsychotics that belong to the phenothiazine family and have a piperazine ethanol side chain.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 170%
Researcher 5 50%
Student > Bachelor 5 50%
Student > Ph. D. Student 2 20%
Other 1 10%
Other 2 20%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 12 120%
Medicine and Dentistry 9 90%
Veterinary Science and Veterinary Medicine 4 40%
Business, Management and Accounting 2 20%
Psychology 2 20%
Other 3 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 April 2017.
All research outputs
#10,023,986
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,154
of 8,923 outputs
Outputs of similar age
#190,970
of 283,398 outputs
Outputs of similar age from Cochrane database of systematic reviews
#214
of 227 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,398 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 227 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.